Metaproterenol sulfate 20 mg Oral Tablet
RxNorm 979475
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 979475 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: metaproterenol sulfate 20 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Metaproterenol sulfate 20 mg Oral Tablet
(Atom ID: 12343800)
PSN
Prescribable Name (PSN):
Metaproterenol sulfate 20 mg Oral Tablet
(Atom ID: 6362818)
PT
Designated preferred name (PT):
Metaproterenol sulfate 20 mg oral tablet
(Atom ID: 11437591)
SY
Synonym (SY):
Orciprenaline sulfate 20 mg oral tablet
(Atom ID: 11437865)
FN
Full form of descriptor (FN):
Product containing precisely orciprenaline sulfate 20 mg/1 each conventional release oral tablet (clinical drug)
(Atom ID: 11440435)
Patient Education
Metaproterenol
Metaproterenol is used to prevent and treat wheezing, shortness of breath, coughing, and chest tightness caused by asthma, chronic bronchitis, emphysema, and other lung diseases. It relaxes and opens air passages in the lungs, making it easier to breathe.
[Learn More]
* Please review the disclaimer below.